About Gt biopharma, inc.

About company

GT Biopharma (formerly Oxis International) specializes in the research and development of therapeutic products used primarily for the treatment of cancer. The group has a portfolio of 4 products in the development phase, including 1 in clinical development phase I (OXS-1550; treatment of acute lymphoblastic leukemia and non-Hodgkin lymphoma) and 3 in the preclinical development phase (OXS-2175, OXS-4135 and OXS-4235; breast cancer, multiple myeloma, and bone disease). Founded in 1965, the company is headquartered in Westlake Village, California, and serves customers worldwide.